TrialDiabetes care2013

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).

Matthew C Riddle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.